Evicenter
MarkdownMedical informationP&T meetings
Darovasertib (IDE196)

First-line metastatic uveal melanoma, in combination with crizotinib

Also known as LXS196
Manufacturer
IDEAYA Biosciences
Launch
Not announced
Last updated
206 sources

Product information and disease descriptionPlace of product in therapyDisease description

Natural history, survival, and mortality

21 evidence topics · 19 sources

Estimated U.S. deaths in 2026, all eye and orbit cancer
Prognostic factors after metastasis: lactate dehydrogenase, alkaline phosphatase, and liver metastasis size